Related references
Note: Only part of the references are listed.The Abundance of Nonphosphorylated Tau in Mouse and Human Tauopathy Brains Revealed by the Use of Phos-Tag Method
Taeko Kimura et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Hypothermia mediates age-dependent increase of tau phosphorylation in db/db mice
Noura B. El Khoury et al.
NEUROBIOLOGY OF DISEASE (2016)
Novel Non-phosphorylated Serine 9/21 GSK3β/α Antibodies: Expanding the Tools for Studying GSK3 Regulation
Tessa Grabinski et al.
Frontiers in Molecular Neuroscience (2016)
Molecular Substrates of Altered Axonal Growth and Brain Connectivity in a Mouse Model of Schizophrenia
Jun Mukai et al.
NEURON (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo
Anna Goc et al.
ONCOTARGET (2014)
Isomerase Pin1 Stimulates Dephosphorylation of Tau Protein at Cyclin-dependent Kinase (Cdk5)-dependent Alzheimer Phosphorylation Sites
Taeko Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin
Bhagat Singh et al.
JOURNAL OF NEUROCHEMISTRY (2012)
GSK-3 and Wnt signaling in neurogenesis and bipolar disorder
Alexander J. Valvezan et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Quantitative Measurement of in Vivo Phosphorylation States of Cdk5 Activator p35 by Phos-tag SDS-PAGE
Tomohisa Hosokawa et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
GSK3 signalling in neural development
Eun-Mi Hur et al.
NATURE REVIEWS NEUROSCIENCE (2010)
GSK3: a multifaceted kinase in Wnt signaling
Dianqing Wu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Separation and detection of large phosphoproteins using Phos-tag SDS-PAGE
Eiji Kinoshita et al.
NATURE PROTOCOLS (2009)
Defective Insulin Signaling Pathway and Increased Glycogen Synthase Kinase-3 Activity in the Brain of Diabetic Mice: Parallels With Alzheimer's Disease and Correction by Insulin
C. G. Jolivalt et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Phosphorylation by p38 MAPK as an alternative pathway for GSK3β inactivation
Tina M. Thornton et al.
SCIENCE (2008)
The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy
W. Matthijs Blankesteijn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
The role of GSK3 in glucose homeostasis and the development of insulin resistance
Jongsoon Lee et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Estradiol, insulin-like growth factor-I and brain aging
Luis M. Garcia-Segura et al.
PSYCHONEUROENDOCRINOLOGY (2007)
Glycogen synthase kinase 3: A key regulator of cellular fate
J. E. Forde et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival
Min-Huei Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
GSK-3 beta regulation in skeletal muscles by adrenaline and insulin: Evidence that PKA and PKB regulate different pools of GSK-3
Jorgen Jensen et al.
CELLULAR SIGNALLING (2007)
A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation
Pamela A. Lochhead et al.
MOLECULAR CELL (2006)
The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation
Florian Plattner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Phosphate-binding tag, a new tool to visualize phosphorylated proteins
E Kinoshita et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Physiological and pathological changes in glucose regulate brain akt and glycogen synthase kinase-3
B Clodfelder-Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin
QQ Ding et al.
MOLECULAR CELL (2005)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event
A Cole et al.
BIOCHEMICAL JOURNAL (2004)
Glycogen synthase kinase 3: a drug target for CNS therapies
RV Bhat et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase
K MacAulay et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes
RS Jope
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
P De Sarno et al.
NEUROPHARMACOLOGY (2002)
Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3β
F Mukai et al.
JOURNAL OF NEUROCHEMISTRY (2002)
GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β-catenin stabilisation without elevation of glycogen synthase activity
AA Culbert et al.
FEBS LETTERS (2001)
Structure of GSK3β reveals a primed phosphorylation mechanism
E ter Haar et al.
NATURE STRUCTURAL BIOLOGY (2001)
Crystal structure of glycogen synthase kinase 3β:: Structural basis for phosphate-primed substrate specificity and autoinhibition
R Dajani et al.
CELL (2001)
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium
WJ Ryves et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
MP Coghlan et al.
CHEMISTRY & BIOLOGY (2000)
Share Paper
